Anthem Biosciences Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
46330.02 Cr.
|
P/BV
|
19.22
|
Book Value (Rs.)
|
42.92
|
52 Week High/Low (Rs.)
|
836/702
|
FV/ML
|
2/1
|
P/E(X)
|
102.67
|
Bookclosure
|
|
EPS (Rs.)
|
8.04
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 |
| | | |
| | | |
INCOME | | | |
Revenue From Operations [Net] | 1844.55 | 1419.37 | 1056.92 |
Total Operating Revenues | 1844.55 | 1419.37 | 1056.92 |
| | | |
Other Income | 85.73 | 63.70 | 77.07 |
Total Revenue | 1930.29 | 1483.07 | 1133.99 |
| | | |
EXPENSES | | | |
Cost Of Materials Consumed | 830.62 | 640.79 | 348.29 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -86.71 | -41.24 | -9.01 |
Employee Benefit Expenses | 260.49 | 182.93 | 153.24 |
Finance Costs | 10.33 | 9.54 | 6.76 |
Depreciation And Amortisation Expenses | 89.37 | 81.82 | 63.70 |
Other Expenses | 169.31 | 131.91 | 135.52 |
Total Expenses | 1273.42 | 1005.75 | 698.50 |
| | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 656.87 | 477.32 | 435.50 |
| | | |
Exceptional Items | 0.00 | 0.00 | 61.80 |
Profit/Loss Before Tax | 656.87 | 477.32 | 497.30 |
| | | |
Tax Expenses-Continued Operations | | | |
Current Tax | 182.03 | 126.41 | 120.05 |
Deferred Tax | 23.58 | -16.40 | -7.94 |
Total Tax Expenses | 205.61 | 110.01 | 112.11 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 451.26 | 367.31 | 385.19 |
| | | |
Profit/Loss From Continuing Operations | 451.26 | 367.31 | 385.19 |
| | | |
Profit/Loss For The Period | 451.26 | 367.31 | 385.19 |
Consolidated Profit/Loss After MI And Associates | 451.26 | 367.31 | 385.19 |
| | | |
OTHER INFORMATION | | | |
| | | |
EARNINGS PER SHARE | | | |
Basic EPS (Rs.) | 8.07 | 6.48 | 6.75 |
Diluted EPS (Rs.) | 8.04 | 6.48 | 6.75 |